Genetic variation associated with childhood and adult stature and risk of MYCN-amplified neuroblastoma

被引:2
|
作者
Semmes, Eleanor C. [1 ,2 ]
Shen, Erica [3 ]
Cohen, Jennifer L. [4 ]
Zhang, Chenan [5 ]
Wei, Qingyi [6 ,7 ]
Hurst, Jillian H. [2 ]
Walsh, Kyle M. [2 ,3 ,5 ,6 ,7 ]
机构
[1] Duke Univ, Med Scientist Training Program, Durham, NC USA
[2] Duke Univ, Dept Pediat, Childrens Hlth & Discovery Inst, Durham, NC 27706 USA
[3] Duke Univ, Div Neuroepidemiol, Dept Neurosurg, Durham, NC USA
[4] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27706 USA
[5] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA
[6] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA
[7] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA
来源
CANCER MEDICINE | 2020年 / 9卷 / 21期
关键词
cancer genetics; Cancer Medicine; cancer risk factors; epidemiology; genome-wide association; height; MYCN; neuroblastoma; pathway analysis; pediatric cancer; polygenic score; stature; GENOME-WIDE ASSOCIATION; OVERGROWTH SYNDROMES; COMMON VARIATION; CANCER; HEIGHT; SUSCEPTIBILITY; VARIANTS; GROWTH; LENGTH; MUTATIONS;
D O I
10.1002/cam4.3458
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Neuroblastoma is the most common pediatric solid tumor. MYCN-amplification is an important negative prognostic indicator and inherited genetic contributions to risk are incompletely understood. Genetic determinants of stature increase risk of several adult and childhood cancers, but have not been studied in neuroblastoma despite elevated neuroblastoma incidence in children with congenital overgrowth syndromes. Methods: We investigated the association between genetic determinants of height and neuroblastoma risk in 1538 neuroblastoma cases, stratified by MYCN-amplification status, and compared to 3390 European-ancestry controls using polygenic scores for birth length (five variants), childhood height (six variants), and adult height (413 variants). We further examined the UK Biobank to evaluate the association of known neuroblastoma risk loci and stature. Results: An increase in the polygenic score for childhood stature, corresponding to a similar to 0.5 cm increase in pre-pubertal height, was associated with greater risk of MYCN-amplified neuroblastoma (OR = 1.14, P = .047). An increase in the polygenic score for adult stature, corresponding to a similar to 1.7 cm increase in adult height attainment, was associated with decreased risk of MYCN-amplified neuroblastoma (OR = 0.87, P = .047). These associations persisted in case-case analyses comparing MYCN-amplified to MYCN-unamplified neuroblastoma. No polygenic height scores were associated with MYCN-unamplified neuroblastoma risk. Previously identified genome-wide association study hits for neuroblastoma (N = 10) were significantly enriched for association with both childhood (P = 4.0 x 10(-3)) and adult height (P = 8.9 x 10(-3)) in >250 000 UK Biobank study participants. Conclusions: Genetic propensity to taller childhood height and shorter adult height were associated with MYCN-amplified neuroblastoma risk, suggesting that biological pathways affecting growth trajectories and pubertal timing may contribute to MYCN-amplified neuroblastoma etiology.
引用
收藏
页码:8216 / 8225
页数:10
相关论文
共 50 条
  • [1] Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma
    Hungate, Eric A.
    Applebaum, Mark A.
    Skol, Andrew D.
    Vaksman, Zalman
    Diamond, Maura
    McDaniel, Lee
    Volchenboum, Samuel L.
    Stranger, Barbara E.
    Maris, John M.
    Diskin, Sharon J.
    Onel, Kenan
    Cohn, Susan L.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (10)
  • [2] GENETIC VARIANTS IN KIF15 ARE ASSOCIATED WITH MYCN-AMPLIFIED NEUROBLASTOMA
    Applebaum, M. A.
    Hungate, E.
    Skol, A.
    Vaksman, Z.
    Diamond, M.
    McDaniel, L.
    Volchenboum, S.
    Stranger, B.
    Diskin, S.
    Maris, J.
    Onel, K.
    Cohn, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S20 - S21
  • [3] Locoregional MYCN-amplified neuroblastoma
    La Madrid, Andres Morales
    Volchenboum, Samuel
    Gastier-Foster, Julie M.
    Pyatt, Robert
    Liu, Don
    Pytel, Peter
    Lavarino, Cinzia
    Rodriguez, Eva
    Cohn, Susan L.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 736 - 738
  • [4] Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma
    Epp, Soraya
    Chuah, Shin Mei
    Halasz, Melinda
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [5] The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
    Misiak, Danny
    Hagemann, Sven
    Bell, Jessica L.
    Busch, Bianca
    Lederer, Marcell
    Bley, Nadine
    Schulte, Johannes H.
    Huttelmaier, Stefan
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] MYCN PARTICIPATES IN A REGULATORY MIRNA NETWORK IN MYCN-AMPLIFIED NEUROBLASTOMA
    Flaegstad, Trond
    Buchner, Jochen
    Henriksen, Jorn
    Lokke, Cecilie
    Tomte, Ellen
    Haug, Bjorn Helge
    Einvik, Christer
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 807 - 807
  • [7] The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma
    Bogen, Dominik
    Brunner, Clemens
    Walder, Diana
    Ziegler, Andrea
    Abbasi, Reza
    Ladenstein, Ruth L.
    Noguera, Rosa
    Martinsson, Tommy
    Amann, Gabriele
    Schilling, Freimut H.
    Ussowicz, Marek
    Benesch, Martin
    Ambros, Peter F.
    Ambros, Inge M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 153 - 163
  • [8] CAMKV as an immunotherapy target in MYCN-amplified neuroblastoma
    Sussman, Robyn T.
    Huang, Kevin
    Raman, Pichai
    Maris, John M.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] Targeting condensin, a vital spot of MYCN-amplified neuroblastoma
    Tanno, Yuji
    Watanabe, Yoshinori
    [J]. CELL CYCLE, 2014, 13 (08) : 1224 - 1224
  • [10] MYCN-amplified neuroblastoma is addicted to iron and vulnerable to ferroptosis
    Floros, Konstantinos V.
    Johnson-Berro, Mia O.
    Kurupi, Richard
    Fairchild, Carter K.
    Dalton, Krista
    Hu, Bin
    Puchalapalli, Madhavi
    Dozmorov, Mikhail G.
    Koblinski, Jennifer E.
    Olzmann, James A.
    Cowart, Lauren A.
    Faber, Anthony C.
    [J]. CANCER RESEARCH, 2022, 82 (12)